Parker Waichman LLP Warns Against Long-Term Use of Fosamax, Other Bisphosphonates … - YAHOO!

In addition to Fosamax, other bisphosphonates include Actonel (risedronate), Boniva (ibandronate), Atelvia (risedronate delayed release), Didronel (etidronate), and Skelid (tiludronate), and Reclast (zoledronic acid injection). According to the NEJM report ...

Long-Term Bisphosphonates May Be OK for Select Patients - Medscape News

and the Actonel Vertebral Efficacy with Risedronate Therapy–Multinational Trial (VERT-MN) extension. All women in the studies had were postmenopausal and had baseline fractures, low bone mineral density T scores (−1.5 or less), or both. The FDA ...

ASBMR responds to NEJM's study on biphosphonates - EurekAlert

Bisphosphonates include the drugs Aclasta, Actonel, Aredia, Bondronat, Boniva, Didronel, Fosamax, Fosavance, Reclast, Skelid and Zometa. The American Society for Bone and Mineral Research (ASBMR) believes that for the vast majority of patients ...

Warner Chilcott to explore sale of company - Yahoo Finance

Warner picked up potentially attractive products with its 2009 purchase of Procter & Gamble's (PG) pharmaceuticals business, including the osteoporosis drug Actonel and the ulcerative colitis drug Asacol. Last week, sources told Reuters that the ...

Warner Chilcott Tops But Cuts View - Yahoo Finance

Revenues in the reported quarter declined 9.5% to $685 million. The decline was primarily attributable to lower sales of its osteoporosis drug, Actonel -- acquired from Procter & Gamble Co. (PG) in 2009 -- due to generic competition. Moreover ...

Warner Chilcott Posts Profit Despite Falling Sales; Outlook Trimmed - NASDAQ

(RTTNews.com) - Irish pharmaceutical firm Warner Chilcott Plc (WCRX), which is mulling a sale of the company, on Friday reported a profit for the first quarter despite a huge drop in sales of its Actonel osteoporosis drug. Significant cost ...

Bone-building drugs' extended use questioned - Sacramento Bee

Actonel and Reclast. The concern is that after years of use, the drugs may in rare cases actually lead to weaker bones in certain women, contributing to "rare but serious adverse events," including unusual femur fractures, esophageal cancer and ...

Bone Drugs May Not Help Women Long Term, FDA Review Says - Businessweek

The agency previously linked the drugs, which include Warner Chilcott Plc (WCRX) (WCRX)’s Actonel and Roche Holding AG (ROG)’s Boniva, to thigh fractures and jawbone deterioration. It is also investigating conflicting studies that the ...

FDA warns of side effects from bone-building drugs - Abc Local Web

In a new study published this week in the New England Journal of Medicine, the Food and Drug Administration repeated previous concerns about serious side effects from the drugs like Fosamax, Actonel and Reclast. The agency said women without osteoporosis ...

Warner Chilcott to explore strategic options - Irish Times

Warner picked up potentially attractive products with its 2009 purchase of Procter Gamble’s pharmaceuticals business, including the osteoporosis drug Actonel and the ulcerative colitis drug Asacol. The German drugs and plastics maker Bayer was last week ...